The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other ...

In a breakthrough that could potentially rewrite the prevention and treatment of cancer, scientists have discovered how ...

Lucent Diagnostics, a brand of Quanterix (QTRX) Corporation, has introduced LucentAD Complete, a new multi-marker blood test designed to help detect Alzheimer’s Disease (AD) in a broader range of ...

BILLERICA, Mass.--(BUSINESS WIRE)--Lucent Diagnostics, a brand of Quanterix Corporation (NASDAQ: QTRX), has introduced LucentAD Complete, a new multi-marker blood test designed to help detect ...

In May, the FDA cleared the first blood-based diagnostic test for Alzheimer's disease, the Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio, intended to be used in people 55 and older who have signs ...

Recent research suggests that blood tests may show markers of oral cancer. But a blood test isn’t enough to confirm an oral cancer diagnosis. A biopsy is the only way to confirm it. Blood tests for ...

After years of being told their crushing exhaustion might be “all in their head,” people with Myalgic ...

Researchers believe they have developed the first dedicated blood test to diagnose chronic fatigue syndrome (CFS), also known ...

Scientists at the University of East Anglia and Oxford Biodynamics have developed a high accuracy blood test to diagnose chronic fatigue syndrome, also known as myalgic encephalomyelitis (ME/CFS).

Researchers from the University of East Anglia and biotechnology company Oxford Biodynamics have developed a new blood test for diagnosing ME/CFS with 96% accuracy.

Researchers developed blood-based metabolic fingerprints that mirror physical fitness in older adults. Machine learning ...

A new study shows that routine hospital blood tests could help predict spinal cord injury severity and survival chances.